ARLENE MORANTE: Open Payments
NPI 1568231462 · N LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,631 in 83 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $1,461 · 2025 $1,631
Food & beverage: $1,631
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $497 |
| Novo Nordisk Inc | 13 | $229 |
| Lilly USA, LLC | 15 | $206 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $181 |
| Dexcom, Inc. | 5 | $99 |
| Amgen Inc. | 2 | $54 |
| PFIZER INC. | 2 | $48 |
| Astellas Pharma US Inc | 2 | $43 |
| Exact Sciences Corporation | 2 | $34 |
| Kowa Pharmaceuticals America, Inc. | 2 | $32 |
Products named: AIRSUPRA, FARXIGA, Kerendia, MOUNJARO, Dexcom G6 Transmitter, ELIQUIS, Veozah, Rybelsus.
Industry payments across NV — which companies pay providers there.
